Allergy Therapeutics plc (LON:AGY – Get Free Report) was down 9.8% during mid-day trading on Wednesday . The stock traded as low as GBX 3.88 ($0.05) and last traded at GBX 3.88 ($0.05). Approximately 536,545 shares were traded during mid-day trading, a decline of 34% from the average daily volume of 817,419 shares. The stock had previously closed at GBX 4.30 ($0.06).
Allergy Therapeutics Trading Up 3.8 %
The firm’s 50-day moving average is GBX 4.86 and its 200-day moving average is GBX 3.89. The company has a current ratio of 1.40, a quick ratio of 1.48 and a debt-to-equity ratio of 37.22. The firm has a market cap of £197.96 million, a price-to-earnings ratio of -66.67, a P/E/G ratio of -30.70 and a beta of 1.45.
About Allergy Therapeutics
Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.
Featured Stories
- Five stocks we like better than Allergy Therapeutics
- What Are Growth Stocks and Investing in Them
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- Comparing and Trading High PE Ratio Stocks
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- About the Markup Calculator
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
